UNSPSC 12161501: Affinity labels

UNSPSC 12161501 Affinity labels, a Commodity code, encompasses diagnostic and forensic laboratory test kits, supplies, and materials that state and local agencies procure for clinical screening, therapeutic drug monitoring, forensic casework, and public health laboratory operations. State and local governments under this code are buying FDA-cleared diagnostic test kits (Clozapine monitoring kits), forensic DNA amplification chemistry and reagents, culture media, stains, antimicrobial susceptibility disks, and laboratory consumables for correctional drug testing, mental health systems, public health departments, and law enforcement forensic labs. The issuing bodies span state health and mental health departments (Mississippi Department of Mental Health), state law enforcement (Oregon State Police), county community supervision and corrections departments (Collin County), county public health departments (San Bernardino County), and county health care services (Collin County). A school district also appears in the dataset but is purchasing science specimens and chemicals outside the forensic and clinical diagnostic scope of this code.

Recent activity concentrates in Texas, California, Mississippi, and Oregon. Representative opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services with annual testing demand of approximately 25,031 tests and an estimated contract value of $600,000 over two years with three optional one-year renewals (response date July 23, 2026); Mississippi Department of Mental Health's sole-source notice for FDA-cleared Clozapine Test Kits (closing objection period September 30, 2026); Oregon State Police's sole-source notice for Promega PowerPlex Y23 forensic DNA amplification kits and supplies with an estimated five-year contract value of $250,000 (protest deadline July 31, 2026); and San Bernardino County Department of Public Health's ITB for laboratory supplies including culture media, stains, reagents, and diagnostic test materials with a five-year pricing agreement structure and anticipated award in September 2026 (response date July 31, 2026).